| 发明名称 | Aqueous compositions comprising arbekacin | ||
| 摘要 | The invention provides aqueous liquid pharmaceutical compositions comprising arbekacin and chloride ions. The compositions are well tolerable for use in a method for treatment or prevention of a disease of the upper or lower respiratory tract, wherein the composition is aerosolized and inhaled by the patient. Furthermore, the invention provides arbekacin hydrochloride. | ||
| 申请公布号 | US9511143(B2) | 申请公布日期 | 2016.12.06 |
| 申请号 | US201214344487 | 申请日期 | 2012.08.03 |
| 申请人 | Meiji Seika Pharma Co., Ltd.;PARI Pharma GmbH | 发明人 | Keller Manfred;Yagi Yukihiro;Tanaka Masashi;Sugano Toshie;Shoji Kuniko;Sano Nao;Hahn Michael;Egle Roman |
| 分类号 | A61K31/7036;C07H15/234;A61K47/02;A61K9/00;A61K47/24;A61K9/19 | 主分类号 | A61K31/7036 |
| 代理机构 | Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. | 代理人 | Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Corless, Esq. Peter F.;Clarke Daniel W. |
| 主权项 | 1. An aqueous liquid pharmaceutical composition comprising arbekacin and chloride ions, wherein the concentration of arbekacin, calculated as free base, is at least 100 mg/ml and the ratio of the molar amount of chloride ions to the molar amount of arbekacin is at least 0.9 : 1. | ||
| 地址 | Tokyo JP | ||